ADO-TRASTUZUMAB EMTANSINE - Food and Drug Administration
- Set ID
- f13c9ced-2bd3-4dc2-aa1a-5bdacbc77671
- Type
- Indexing - product concept
- Effective date
- 2019-07-31
- Version
- 1
- Source
- DailyMed source
Mapped DailyMed Labels#
| Label | Relation | Manufacturer | Effective |
|---|---|---|---|
| These highlights do not include all the information needed to use KADCYLA safely and effectively. See full prescribing information for KADCYLA. KADCYLA ® (ado-trastuzumab emtansine) for injection, for intravenous use Initial U.S. Approval: 2013 | Product name | Genentech, Inc. | Genentech, Inc. (Hillsboro) | F. Hoffmann-La Roche AG | Roche Diagnostics GmbH | Lonza Biologics Tuas Pte Ltd. | Roche Singapore Technical Operations Pte. Ltd | 2026-04-01 |
| These highlights do not include all the information needed to use KADCYLA safely and effectively. See full prescribing information for KADCYLA. KADCYLA ® (ado-trastuzumab emtansine) for injection, for intravenous use Initial U.S. Approval: 2013 | Product name | Genentech, Inc. | Genentech, Inc. (Hillsboro) | F. Hoffmann-La Roche AG | Roche Diagnostics GmbH | Lonza Biologics Tuas Pte Ltd. | Roche Singapore Technical Operations Pte. Ltd | 2025-11-21 |